About | Free Trial

Last Update

2016-01-16T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Tom Geimer?

Dr. Tom Geimer

Managing Director

Madeleine Pharmaceuticals

Direct Phone: +61 **********       

Madeleine Pharmaceuticals

Company Description

Madeleine Pharmaceuticals is privately held company located in Adelaide, Australia. Founded in 2009 as a spin out from Hospira, Inc, the company is focussed on the development of peptide therapeutics for cardio-renal diseases. Madeleine Pharmaceutical's ... more

Find other employees at this company (13)

Background Information

Employment History

Venture Partner
Heidelberg Innovation

Affiliations

Director
Apax Partners LLP

Board Member
BioImage A/S

Founder
Cettera Pty Ltd

Founder
U3 Pharma AG

Education

Bachelors degree
molecular biology

Honours degree
Molecular Biology

MBA

London Business School

PhD
veterinary science
Hannover , Germany

PhD
veterinary science
University of Wisconsin at Madison

degree
molecular biology
University of Wisconsin at Madison

honors degree
molecular biology
University of Wisconsin at Madison

Web References (23 Total References)


Tom ...

madeleine-pharma.com [cached]

Tom Geimer Tom is Managing Director of Madeleine Pharmaceuticals. He has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was previously a Venture Partner with Heidelberg Innovation following five years as a Senior Partner with Apax. Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals including Wilex, Zymogenitics, Metagen, BioImage and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. He was also founder of U3 Pharma which was subsequently sold to Daiichi Sankyo. In 2008, Tom moved at the invitation of the government to Australia as the Entrepreneur in Residence for Biotechnology in South Australia, co-founded Terra Rossa Capital and subsequently progressed selected opportunities to companies, for example, Madeleine Pharmaceuticals. Tom has a degree in molecular biology (Honors) from University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar.


Tom ...

madeleine-pharma.com [cached]

Tom Geimer Operations


Team | Madeleine Pharmaceuticals

madeleine-pharma.com [cached]

Tom Geimer -Managing Director

...
Tom is Managing Director of Madeleine. He has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was previously a Venture Partner with Heidelberg Innovation following five years as a Senior Partner with Apax.
Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals including Wilex, Zymogenitics, Metagen, BioImage and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. He was also founder of U3 Pharma which was subsequently sold to Daiichi Sankyo.
In 2008, Tom moved at the invitation of the government to Australia as the Entrepreneur in Residence for Biotechnology in South Australia, co-founded Terra Rossa Capital and subsequently progressed selected opportunities to companies, for example, Madeleine.
Tom has a degree in molecular biology (Honors) from University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar.


About Us | Cettera

cettera.com [cached]

Cettera Pty Ltd (ABN: 30122909737) was founded by Dr. Tom Geimer and began operations in Australia in early 2007.

Andrew Grant joined Cettera in 2010 after working on several projects with Tom.
...
Tom has training and work experience in stockbroking, corporate finance and most importantly early stage and growth venture capital.
...
Tom has worked in the pharmaceutical and biotech industries at various levels also having put his hands to work as a veterinarian for a few years.
...
Tom has worked internationally in the commercialisation sector for the past 15 years, and is an experienced venture capitalist. He has held positions in various start-up companies and corporate management in Europe. His area of expertise is science and pharmaceuticals. He has a Bachelors degree in molecular biology, a Doctor of Philosophy in veterinary science and a Masters of Business Administration.


Madeleine Pharmaceuticals | Cettera

cettera.com [cached]

Madeleine Pharmaceuticals Pty Ltd (Madeleine) was founded in June 2009 by the Entrepreneur in Residence (EIR) for BioInnovation SA (BioSA), namely: Dr. Tom Geimer (Founder).

...
More on Madeleine by contacting Tom Geimer
tom.geimer@madeleine-pharma.com

Similar Profiles

Other People with this Name

Other people with the name Geimer

Amy Geimer
loanDepot.com LLC

Geoff Geimer
Equinix Inc

Kathryn Geimer

Silke Geimer
Assenagon Asset Management

Jennifer Geimer
CEB Inc.

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory